Back to Search
Start Over
Caprine Mucopolysaccharidosis IIID: A Preliminary Trial of Enzyme Replacement Therapy
Caprine Mucopolysaccharidosis IIID: A Preliminary Trial of Enzyme Replacement Therapy
- Source :
- Journal of Molecular Neuroscience. 15:251-262
- Publication Year :
- 2000
- Publisher :
- Springer Science and Business Media LLC, 2000.
-
Abstract
- Mucopolysaccharidosis type IIID (MPS IIID) is a lysosomal storage disorder resulting from lack of activity of the lysosomal hydrolase N-acetylglucosamine 6-sulfatase (6S) (EC 3.1.6.14). The syndrome is associated with systemic and central nervous system (CNS) heparan sulfate glycosaminoglycan (HS-GAG) accumulation, secondary storage of lipids, and severe, progressive dementia. In this investigation, caprine MPS IIID, established as a large animal model for the human disease, was used to evaluate the efficacy of enzyme replacement therapy (ERT). Recombinant caprine 6S (rc6S) (1 mg/kg/dose) was administered intravenously to one MPS IIID goat kid at 2, 3, and 4 wks of age. Five days after the last dose, the uronic acid (UA) content and the composition of uncatabolized HS-GAG fractions in the brain of the ERT-treated MPS IIID kid were similar to those from a control, untreated MPS IIID animal. However, hepatic uronic acid levels in the treated MPS IIID kid were approximately 90% lower than those in the untreated MPS IIID control; whereas the composition of the residual hepatic HS-GAG was identical to that in the untreated animal. Marked reduction of lysosomal storage vacuoles in hepatic cells of the treated MPS IIID kid was observed, but ERT had no effect on CNS lesions. No residual 6S activity was detected in brain or liver. This preliminary investigation indicates that other treatment regimens will be necessary to ameliorate MPS III-related CNS lesions.
- Subjects :
- Male
congenital, hereditary, and neonatal diseases and abnormalities
medicine.medical_specialty
Mucopolysaccharidosis
Biology
Glycosaminoglycan
Mucopolysaccharidosis III
Cellular and Molecular Neuroscience
chemistry.chemical_compound
Internal medicine
medicine
Animals
Glycosaminoglycans
Sanfilippo syndrome
Neurons
Mucopolysaccharidosis Type IIID
Goats
Brain
nutritional and metabolic diseases
General Medicine
Heparan sulfate
Enzyme replacement therapy
medicine.disease
N-acetylglucosamine-6-sulfatase
Recombinant Proteins
Disease Models, Animal
Treatment Outcome
Uronic Acids
Endocrinology
Liver
chemistry
Immunology
Hepatocytes
Hepatic stellate cell
Electrophoresis, Polyacrylamide Gel
Female
Heparitin Sulfate
Sulfatases
Subjects
Details
- ISSN :
- 08958696
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- Journal of Molecular Neuroscience
- Accession number :
- edsair.doi.dedup.....942786457c6559e72897e351a5ad76e4
- Full Text :
- https://doi.org/10.1385/jmn:15:3:251